Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-17

Clinical Trial Update: Safety of Intravenous Thrombolytics in Stroke on Awakening [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety of intravenous thrombolytics for stroke in patients who awaken with symptoms; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Stroke | Phase 2 | Status: COMPLETED | Results posted: 2017-04-17